Cargando…

P19-10. Induction of dendritic cell maturation by a liposomally-delivered multivalent HIV vaccine

Detalles Bibliográficos
Autores principales:	Azizi, A, Sirskyj, D, Saad, A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767838/ http://dx.doi.org/10.1186/1742-4690-6-S3-P330

Ejemplares similares

Multivalent adenoviral vectors which use an antigen capsid-incorporation strategy for HIV vaccination
por: Gu, L, et al.
Publicado: (2012)

P19-15. Synthesis of multivalent mimotopes as potential vaccine candidates
por: Go, JG, et al.
Publicado: (2009)

P10-04. Mechanisms of HIV-1 detection by plasmacytoid dendritic cells
por: Lepelley, A, et al.
Publicado: (2009)

P18-10. Ability of HIV antigens-pulsed monocyte-derived dendritic cells to induce HIV-specific T cell response: potential use in therapeutic vaccine
por: Silveira, GG, et al.
Publicado: (2009)

Defective maturation of dendritic cells during HIV-1 infection is associated with increased expression of SOCS-1
por: Sachdeva, Meenakshi, et al.
Publicado: (2012)

Enhanced induction of HIV-specific CTL by dendritic cell-targeted delivery of SOCS-1 siRNA
por: Subramanya, Sandesh, et al.
Publicado: (2010)

The emptied bacteriophage T4 head: a novel nanoparticle vehicle to simultaneously deliver HIV-1 antigens and genes into dendritic cells
por: Rao, V
Publicado: (2012)

P10-05. Suppression of human dendritic cell function during acute HIV infection
por: Frleta, D, et al.
Publicado: (2009)

HIV-1 gp120 impairs the induction of B cell responses by TLR9-activated plasmacytoid dendritic cells
por: Chung, NP, et al.
Publicado: (2012)

P14-10. Comparable immunogenicity of VRC DNA and rAd5 HIV-1 vaccines delivered by intramuscular, subcutaneous and intradermal routes in healthy adults (VRC 011)
por: Ledgerwood, JE, et al.
Publicado: (2009)

Induction of type II collagen-reactive IL-10-producing CD11b(+ )dendritic cells in Payer's patch of orally tolerized animals
por: Kim, H, et al.
Publicado: (2003)

Tolerogenic dendritic cells in experimental autoimmune encephalomyelitis, specific tolerance induction?
por: Sellés-Moreno, Carla, et al.
Publicado: (2012)

Vaccination with dendritic cells loaded with HIV-1 lipopeptides elicits broad T cell immunity and control of viral load in HIV infected patients
por: Levy, Y, et al.
Publicado: (2012)

P19-43. Regulatory T cell epitopes in a dendritic cell-targeted HIV vaccine delivery platform
por: Weber, C, et al.
Publicado: (2009)

P19-45. Development of a therapeutic HIV vaccine comprised of autologous dendritic cells loaded with a mixture of lipopeptide HIV antigens
por: Cobb, AJ, et al.
Publicado: (2009)

Design of lipid nanoparticle delivery agents for multivalent display of recombinant Env trimers in HIV vaccination
por: Pejawar-Gaddy, S, et al.
Publicado: (2012)

In vivo induction of foxp3 in collagen-induced arthritis treatment with modified dendritic cells
por: Falgarone, G, et al.
Publicado: (2005)

Induction of HIV-1 Gag-specific memory T cells in Chacma baboons by MVA prime and VLP boost vaccine regimen
por: Singh, V, et al.
Publicado: (2012)

Mechanisms Underlying the Immune Response Generated by an Oral Vibrio cholerae Vaccine
por: Sirskyj, Danylo, et al.
Publicado: (2016)

CCL19-sorted mature dendritic cells have enhanced lymph node migratory capacity and function
por: Le Brocq, Michelle L, et al.
Publicado: (2015)

P19-26. Directing macaque immune responses with an anti-dendritic cell HIV Gag p24 fusion protein vaccine
por: Martinon, F, et al.
Publicado: (2009)

P10-13. Increased production of alpha-defensins 1–3 by dendritic cells in HIV-infected individuals is associated with a slower disease progression rate
por: Rodriguez-Garcia, M, et al.
Publicado: (2009)

Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans
por: Katinger, D, et al.
Publicado: (2012)

Induction of hypoxia inducible factor 1α by Toll-like receptors in human dendritic cells
por: Djafarzadeh, S, et al.
Publicado: (2008)

HIV-1 infection in dendritic cells in HAART suppressed patients
por: Maldonado, lrvin M, et al.
Publicado: (2006)

Selective costimulation by IL-15R/IL-15, but not IL-2R/IL-2, allows the induction of high numbers of tumor-specific CD8+ T cells by human dendritic cells matured in conditions of acute inflammation
por: Hansen, Morten, et al.
Publicado: (2015)

Skin tattooing as an effective tool for delivering DNA and protein vaccine immunogens
por: Chiu, Y, et al.
Publicado: (2012)

Infections from MDR strains (K. pneumoniae, P. aeruginosa, A. Baumannii complex) in a multivalent ICU
por: Kontopoulou, K, et al.
Publicado: (2014)

P55. Dendritic cell vaccination for postremission therapy in AML
por: Lichtenegger, FS, et al.
Publicado: (2014)

P18-08. Characterization of CD34+ derived dendritic cells generated in vitro and transfected with HIV gene as potential therapeutic vaccine in macaque
por: Romain, G, et al.
Publicado: (2009)

Multivalency in a Dendritic Host–Guest System
por: Smeijers, A. F., et al.
Publicado: (2019)

P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection
por: Lederle, A, et al.
Publicado: (2009)

Tailored Multivalent Targeting of Siglecs with Photosensitizing Liposome Nanocarriers
por: Almeida‐Marrero, Verónica, et al.
Publicado: (2022)

Modulation of HIV-1 replication in primary dendritic cells in contact with autologous CD4 T-lymphocytes
por: Su, B, et al.
Publicado: (2012)

Adjuvant dendritic cell vaccination in high-risk uveal melanoma patients
por: Bol, Kalijn, et al.
Publicado: (2015)

Using Multivalent Adenoviral Vectors for HIV Vaccination
por: Gu, Linlin, et al.
Publicado: (2013)

P18-07. Ex vivo production of autologous HIV-1 to be used as immunogen in autologous dendritic cell-based therapeutic vaccine (clinical trial DCV02)
por: Gil, C, et al.
Publicado: (2009)

P17-10. A new AuxoGTU-HIV B DNA vaccine induce very long lasting HIV specific T cells response which is efficiently boosted with HIV LAI lipopeptides
por: Mangeot-Méderlé, I, et al.
Publicado: (2009)

P18-13 LB. Immunogenicity of an autologous dendritic cell anti-HIV therapy in HIV-1 infected individuals
por: Yassine Diab, B, et al.
Publicado: (2009)

P20-06. Study of viral variability evolution in patients submitted to a therapeutic vaccine based on autologous dendritic cells pulsed with autologous HIV-1
por: Guilà, M, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_7f767dqplh33mq80o933rb2mto